Abrdn PLC Pyxis Oncology, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Abrdn PLC holds 913,045 shares of PYXS stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
913,045
Previous 913,045
-0.0%
Holding current value
$3.23 Million
Previous $894,000
12.3%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PYXS
# of Institutions
72Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$12.8 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$12.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$9.86 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$8.85 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$7.61 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $124M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...